The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2025-04-11
- Target Recruit Count
- 76
- Registration Number
- NCT02451982
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2024-10-21
- Target Recruit Count
- 60
- Registration Number
- NCT02452008
- Locations
- 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Survivorship Promotion In Reducing IGF-1 Trial
- Conditions
- Melanoma of SkinEndometrial CancerLiver CancerPancreatic CancerRectal CancerKidney CancerOther Solid Malignant TumorsBreast CancerProstate CancerLung Cancer
- Interventions
- Behavioral: Self-control weight lossBehavioral: Coach Directed Behavioral Weight Loss
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 121
- Registration Number
- NCT02431676
- Locations
- 🇺🇸
Johns Hopkins ProHealth, Baltimore, Maryland, United States
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
- Conditions
- Advanced Prostate Cancer
- Interventions
- Drug: Pelvic DCFPyL PET-MRI fusion or PET/MRI
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2025-03-19
- Target Recruit Count
- 23
- Registration Number
- NCT02420977
- Locations
- 🇺🇸
Curtiland Deville, Baltimore, Maryland, United States
Vibrent Smartphone Mobile Application
- Conditions
- Mucositis
- Interventions
- Other: Vibrogent Smartphone Application
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2023-01-17
- Target Recruit Count
- 48
- Registration Number
- NCT02421536
- Locations
- 🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
Patient and Provider Initiated Survivorship Care Planning
- Conditions
- Cancer
- Interventions
- Other: 'My Care Plan'Other: 'Survivorship Care Plan Builder'
- First Posted Date
- 2015-04-01
- Last Posted Date
- 2016-04-21
- Target Recruit Count
- 41
- Registration Number
- NCT02405819
- Locations
- 🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸Sibley Memorial Hospital, Washington, District of Columbia, United States
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
- Conditions
- HPV16 Associated Cervical Cancer
- Interventions
- First Posted Date
- 2015-04-01
- Last Posted Date
- 2025-03-04
- Target Recruit Count
- 14
- Registration Number
- NCT02405221
- Locations
- 🇺🇸
Women & Infants Center, University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
- Conditions
- Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)Prostate Cancer
- Interventions
- Radiation: Radium 223
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
- Conditions
- Blood Brain Barrier Defect
- Interventions
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2018-11-20
- Target Recruit Count
- 6
- Registration Number
- NCT02389738
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States